Abbott Laboratories (ABT)

Historical Portfolio Holders from 2014 to 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$1.23B
Holdings value Q1 2024
$140B
Value change Q1 2024
-$2.47B
Grand Portfolio weight change Q1 2024
-0.005%
Number of holders
2864
Number of Buys Q1 2024
1217
Number of Sells Q1 2024
-1213
Average Buys Q1 2024 %
+0.014%
Average Sells Q1 2024 %
-0.015%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 1.23B $139B -$2.54B $113.66 2,771
2023 Q4 1.27B $139B +$3.18B $110.07 2,870
2023 Q3 1.27B $123B -$460M $96.85 2,678
2023 Q2 1.28B $139B +$261M $109.02 2,743
2023 Q1 1.28B $129B +$1.74B $101.26 2,711
2022 Q4 1.29B $170B +$28.5B $109.79 2,786
2022 Q3 1.29B $125B +$394M $96.76 2,646
2022 Q2 1.29B $140B +$1.34B $108.65 2,707
2022 Q1 1.29B $152B -$913M $118.36 2,782
2021 Q4 1.3B $182B -$630M $140.74 2,835
2021 Q3 1.3B $153B -$309M $118.13 2,563
2021 Q2 1.3B $151B -$665M $115.93 2,543
2021 Q1 1.31B $158B +$1.94B $119.84 2,553
2020 Q4 1.31B $143B +$536M $109.49 2,518
2020 Q3 1.31B $142B +$451M $108.83 2,351
2020 Q2 1.3B $119B -$1.07B $91.43 2,280
2020 Q1 1.32B $104B +$178M $78.91 2,178
2019 Q4 1.32B $115B +$1.05B $86.86 2,237
2019 Q3 1.32B $110B +$301M $83.67 2,076
2019 Q2 1.32B $111B +$3.57B $84.10 2,064
2019 Q1 1.31B $105B -$151M $79.94 2,053
2018 Q4 1.32B $95.5B +$2.06B $72.33 2,025
2018 Q3 1.29B $95B +$3.33B $73.36 1,921
2018 Q2 1.25B $76.5B +$368M $60.99 1,852
2018 Q1 1.27B $76.3B +$479M $59.92 1,853
2017 Q4 1.27B $72.3B -$173M $57.07 1,800
2017 Q3 1.27B $67.9B +$964M $53.36 1,657
2017 Q2 1.26B $61.4B +$1.1B $48.61 1,635
2017 Q1 1.25B $55.6B +$11B $44.41 1,655
2016 Q4 1.11B $42.5B +$985M $38.41 1,579
2016 Q3 1.09B $46.2B +$970M $42.29 1,553
2016 Q2 1.08B $43B +$2.46B $39.31 1,531
2016 Q1 1.04B $42.8B +$30M $41.83 1,505
2015 Q4 1.03B $46.2B -$60.4M $44.91 1,552
2015 Q3 1.04B $41.8B +$682M $40.22 1,499
2015 Q2 1.03B $49.6B +$465M $49.08 1,525
2015 Q1 1.03B $47.7B -$151M $46.33 1,503
2014 Q4 1.05B $47B +$610M $45.02 1,523
2014 Q3 1.03B $42.8B +$435M $41.59 1,435
2014 Q2 1.02B $41.7B +$371M $40.90 1,419
2014 Q1 1.02B $39.2B -$577M $38.51 1,411